Track: Pediatric Cancer & Immunotherapy

Pediatric Cancer & Immunotherapy

The Pediatric Cancer & Immunotherapy session highlights leading-edge treatments in childhood cancers, with a focus on immunological and molecular innovations. It covers translational oncology research, treatment toxicity management, supportive care, and the growing role of genomics in pediatric cancer therapies.


CAR-T Cell Therapy: Discover its efficacy and safety profile in hematologic malignancies among pediatric patients.


Tumor Profiling & Targeted Therapy: Explore molecular diagnostics guiding personalized interventions.


Pediatric Oncology Supportive Care: Understand best practices in pain management, nutrition, and emotional well-being.


Survivorship & Late Effects Monitoring: Learn how to ensure long-term quality of life and organ health post-treatment.


Onco-Immunology Advances: Analyze new therapies leveraging immune checkpoint inhibitors and vaccine platforms.


Contribute your research to the evolving field of pediatric oncology by submitting your abstract.